You have 9 free searches left this month | for more free features.

City

Houston (2)

Condition

Head and Neck Cancer (1)

Lung Cancer (1)

Overall Status

Active, not recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (2)

Collaborator

Astellas Pharma Inc (1)

Genentech, Inc. (1)

The Kadoorie Charitable Foundations (1)

Study Documents

Intervention Type

drug (2)

behavioral (1)

other (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

CP358774

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Head Neck Cancer Trial in Houston (drug, other, behavioral)

Active, not recruiting

Head and Neck Cancer

Docetaxel
+5 more

Houston, Texas

University of Texas MD Anderson Cancer Center

Jan 31, 2022

Lung Cancer Trial in Houston (Onartuzumab, Erlotinib, Paclitaxel)

Withdrawn

Lung Cancer

Onartuzumab
+4 more

Houston, Texas

University of Texas MD Anderson Cancer Center

Apr 22, 2014